Page 80 - Read Online
P. 80

Matiasek et al. Plast Aesthet Res 2018;5:36  I  http://dx.doi.org/10.20517/2347-9264.2018.50                                      Page 11 of 11

               12.  Desai KK, Hahn E, Pilikkotill B, Lee E. Negative pressure wound therapy: an algorithm. Clin Plast Surg 2012;39:311-24.
               13.  Wolvos TA. Negative pressure wound therapy with instillation: the current state of the art. Surg Technol Int 2014;24:53-62.
               14.  O’Meara S, Cullum N, Majid M, Sheldon T. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds;
                   (4) diabetic foot ulceration. Health Technol Assess 2000;4:1-237.
               15.  ECDC. The bacterial challenge: time to react. Available from: http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_
                   Bacterial_Challenge_Time_to_React.pdf. [Last accessed on 16 Sep 2018]
               16.  Kim T, Oh PI, Simor AE. The economic impact of methicillin-resistant staphylococcus aureus in Canadian hospitals. Infect Control Hosp
                   Epidemiol 2001;22:99-104.
               17.  Macedo-Viñas M, De Angelis G, Rohner P, Safran E, Stewardson A, Fankhauser C, Schrenzel J, Pittet D, Harbarth S. Burden of methicillin-
                   resistant staphylococcus aureus infection at a Swiss University hospital: excess length of stay and costs. J Hosp Infect 2013;84:132-7.
               18.  Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-
                   resistant and methicillin-susceptible staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53-9.
               19.  Dodds Ashley ES, Carroll DN, Engemann JJ, Harris AD, Fowler VG Jr, Sexton DJ, Kaye KS. Risk factors for postoperative mediastinitis
                   due to methicillin-resistant staphylococcus aureus. Clin Infect Dis 2004;38:1555-60.
               20.  Hübner NO, Siebert J, Kramer A. Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds. Skin
                   Pharmacol Physiol 2010;23:244-58.
               21.  Stahl J, Braun M, Siebert J, Kietzmann M. The effect of a combination of 0.1% octenidine dihydrochloride and 2% 2-pheoxyethanol
                   (octenisept) on wound healing in pigs in vivo and its in vitro percutaneous permeation through intact and barrier disrupted porcine skin.
                   Int Wound J 2010;7:62-9.
               22.  Harbs  N,  Siebert  J.  In  vitro  efficacy  of  octenidine  and  polihexanide  against  biofilms  composed  of  pseudomonas  aeruginosa.  GMS
                   Krankenhaushyg Interdiszip 2007;2:Doc45.
               23.  Müller G, Kramer A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity.
                   J Antimicrob Chemother 2008;61:1281-7.
               24.  Vogt PM. Praxis der plastischen chirurgie. Berlin: Springer; 2011.
               25.  Rubin JA, Whetzel TP, Stevenson TR. The posterior thigh fasciocutaneous flap: vascular anatomy and clinical application. Plast Reconstr
                   Surg 1995;95:1228-39.
               26.  Kim PJ, Attinger CE, Steinberg JS, Evans KK, Lehner B, Willy C, Lavery L, Wolvos T, Orgill D, Ennis W, Lantis J, Gabriel A, Schultz
                   G. Negative-pressure wound therapy with instillation: international consensus guidelines. Plast Reconstr Surg 2013;132:1569-79.
               27.  Ludolph I, Fried FW, Kneppe K, Arkudas A, Schmitz M, Horch RE. Negative pressure wound treatment with computer-controlled
                   irrigation/instillation decreases bacterial load in contaminated wounds and facilitates wound closure. Int Wound J 2018; doi: 10.1111/
                   iwj.12958.
   75   76   77   78   79   80   81   82   83   84   85